Global /South Korea /Healthcare /Drug Manufacturers - General /002720

Kukje Pharma Co., Ltd.

002720

• KRX: 002720 • Delayed

4,710KRW -1.5%

3.12 USD

As of 19 June 2026, Kukje Pharma Co., Ltd. has a market cap of $62.88M USD, ranking #28932 globally and #1567 in South Korea. It ranks #2628 in the Healthcare sector, and #933 in the Drug Manufacturers - General industry.

Global Rank

28932

Country Rank

1567

Sector Rank

2628

Industry Rank

933

Key Stats

Market Cap

$62.88MUSD

95.91B KRW

Enterprise Value

$76.59MUSD

115.6B KRW

Revenue (TTM)

$115.06MUSD

175.5B KRW

EBITDA (TTM)

$6.24MUSD

9.41B KRW

Net Income (TTM)

$3.74MUSD

5.7B KRW

EBITDA Margin

5.4%

Profit Margin

3.2%

PE Ratio

16.8

PS Ratio

0.5

PB Ratio

1.0

EV/EBITDA

12.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Tae-hoon Nam open_in_new

Employees

248

Founded

1959

Website

kukjepharm.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.5%	0.1%	-6.8%	3.9%	8.8%	11%	1.8%	5.5%	-32%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	002720 국제약품(주) ISIN: KR7002720001 Shares Out.: Shares Outstanding: 21.16M¹ Shares Float: 13.132M² TV: TradingView: KRX: 002720 SA: Stock Analysis: KRX: 002720 YF: Yahoo Finance: 002720.KS GF: Google Finance: KRX: 002720 BA: Barron's: 002720 MS: Morningstar: XKRX: 002720	4,710 KRW	TV: TradingView: KRX: 002720 SA: Stock Analysis: KRX: 002720 YF: Yahoo Finance: 002720.KS GF: Google Finance: KRX: 002720 BA: Barron's: 002720 MS: Morningstar: XKRX: 002720

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kukje Pharma Co., Ltd.

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, other ETC products, and other products. Kukje Pharma Co., Ltd. was founded in 1959 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.12B 13.91T KRW 14K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.75B 10.3T KRW 11K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.23B 7.97T KRW 8K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.95B 7.55T KRW 8K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.54B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.43B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 870K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 573K%	97.4	United States
Roche Holding AG SIX: RO	$321.45B 256.25B CHF 511K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$287.52B 215.59B GBP 457K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.59B 218.9B CHF 437K%	20.5	Switzerland

chevron_leftBack